Protecting tissue and mitigating injury from chemical exposure
AssigneeHumanetics Corporation
InventorsMichael D. Kaytor, John C. Dykstra
Life of this patent
Estimating the term…
Abstract
Materials and methods for reducing, preventing, or mitigating the effects of exposure to toxic chemical agents.
Claims38
A method for preventing or reducing, in a human subject, one or more effects of exposure to a toxic chemical agent, comprising administering to the subject a composition comprising nanoparticulate genistein, wherein the composition has a nanoparticulate genistein concentration between about 250 mg/mL and about 500 mg/mL, and wherein the subject is identified as being at risk for exposure to the toxic chemical agent.
(canceled)
4-7. (canceled)
10-14. (canceled)
17-18. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for mitigating, in a human subject, one or more effects of exposure to a toxic chemical agent, comprising administering to the subject a composition comprising nanoparticulate genistein, wherein the subject is identified as having been exposed to the toxic chemical agent, and wherein the composition has a nanoparticulate genistein concentration between about 250 mg/mL and about 500 mg/mL.
(canceled)
31-34. (canceled)
37-41. (canceled)
44-45. (canceled)
(canceled)
50-52. (canceled)
(canceled)
56-68. (canceled)
Dependencies are inferred from the claim text.